Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Navigation/Suche
- Forscher*innen
- Institutionen
- Projekte
- Publikationen
- Partner
- Geldgeber
- Ausstattung
- Knowhow
- Forschungsfelder
"Köpfe" der aktuellen Meldungen:
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Tupova, L; Hirschmugl, B; Sucha, S; Pilarova, V; Székely, V; Bakos, É; Novakova, L; Özvegy-Laczka, C; Wadsack, C; Ceckova, M.
Interplay of drug transporters P-glycoprotein (MDR1), MRP1, OATP1A2 and OATP1B3 in passage of maraviroc across human placenta.
Biomed Pharmacother. 2020; 129(11):110506-110506
Doi: 10.1016/j.biopha.2020.110506
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Hirschmugl Birgit
- Wadsack Christian
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Special attention is required when pharmacological treatment is indicated for a pregnant woman. P-glycoprotein (MDR1) is a well-known transporter localized in the maternal blood-facing apical membrane of placental syncytiotrophoblast and is considered to play an important role in protecting the developing fetus. Maraviroc, a MDR1 substrate that is registered for treatment of HIV infection, shows a low toxicity profile, suggesting favorable tolerability also if administered to pregnant women. Nevertheless, there is only poor understanding to date regarding the extent to which it permeates across the placental barrier and what are the transport mechanisms involved. Endeavoring to clarify the passage of maraviroc across placenta, we used in this study the method of closed-circuit perfusion of maraviroc across human placental cotyledon. The data obtained confirmed slight involvement of MDR1, but they also suggest possible interaction with other transport system(s) working in the opposite direction from that of MDR1. Complementary in vitro studies, including cellular experiments on choriocarcinoma BeWo cells as well as transporter-overexpressing MDCKII and A431 cell lines and accumulation in placental fresh villous fragments, revealed maraviroc transport by MRP1, OATP1A2, and OATP1B3 transporters. Based on mRNA expression data in the placental tissue, isolated trophoblasts, and fetal endothelial cells, especially MRP1 and OATP1A2 seem to play a crucial role in cooperatively driving maraviroc into placental tissue. By the example of maraviroc, we show here the important interplay of transporters in placental drug handling and its possibility to overcome the MDR1-mediated efflux. Copyright © 2020 The Authors. Published by Elsevier Masson SAS.. All rights reserved.
- Find related publications in this database (using NLM MeSH Indexing)
- ATP Binding Cassette Transporter, Subfamily B - antagonists & inhibitors
- ATP Binding Cassette Transporter, Subfamily B - genetics
- ATP Binding Cassette Transporter, Subfamily B - metabolism
- Acridines - pharmacology
- Animals -
- Anti-HIV Agents - blood
- Anti-HIV Agents - metabolism
- Anti-HIV Agents - pharmacology
- Cell Line, Tumor -
- Dogs -
- Drug Interactions -
- Female -
- Gene Expression Regulation -
- Humans -
- Madin Darby Canine Kidney Cells -
- Maraviroc - blood
- Maraviroc - metabolism
- Multidrug Resistance-Associated Proteins - genetics
- Multidrug Resistance-Associated Proteins - metabolism
- Organic Anion Transporters - antagonists & inhibitors
- Organic Anion Transporters - genetics
- Organic Anion Transporters - metabolism
- Perfusion -
- Placenta - drug effects
- Placenta - metabolism
- Placental Circulation -
- Pregnancy -
- Ritonavir - pharmacology
- Solute Carrier Organic Anion Transporter Family Member 1B3 - antagonists & inhibitors
- Solute Carrier Organic Anion Transporter Family Member 1B3 - genetics
- Solute Carrier Organic Anion Transporter Family Member 1B3 - metabolism
- Tetrahydroisoquinolines - pharmacology
- Find related publications in this database (Keywords)
- Maraviroc
- Drug transporters
- MRP1
- OATP
- Placenta
- Drug-drug interactions